UBS Group’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541 | Sell |
|
|||||
|
2025
Q1 | $26.2K | Sell |
|
|||||
|
2024
Q4 | $85.6K | Buy |
|
|||||
|
2024
Q3 | $39.6K | Sell |
|
|||||
|
2024
Q2 | $64.7K | Sell |
|
|||||
|
2024
Q1 | $91.1K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $975 | Sell |
|
|||||
|
2023
Q2 | $127K | Buy |
|
|||||
|
2023
Q1 | $68.5K | Buy |
|
|||||
|
2022
Q4 | $54.7K | Buy |
|